Aging is a key risk factor associated with the associated onset of cardiovascular disease. Notably, vascular aging and cardiovascular disease are both with endothelial dysfunction, or a marked decrease in production and bioavailability the vasodilator of nitric oxide (NO). As a result of decreased nitric oxide availability, aging vessels often exhibit endothelial cell senescence and increased oxidative stress. One of the most potent activators of NO production is fluid shear stress produced by blood flow. Interestingly, age-related decrease in NO production partially results from endothelial insensitivity to shear stress. While the endothelial cell response to fluid shear stress has been well characterized in recent years, the exact mechanisms of how the mechanical force of fluid shear stress is converted into intracellular biochemical signals are relatively unknown. Therefore, gaining a better knowledge of mechanosignaling events in endothelial cells may prove to be beneficial for developing potential therapies for cardiovascular diseases.
Nitric oxide is a critical vasodilator produced by ECs. Physiologically, NO continually regulates vascular tone by mediating vessel lumen diameter and vasodilation. However, NO has other roles in the endothelium as well; inhibiting vascular inflammation, thrombotic events, and aberrant cell proliferation (Heffernan et al., 2010) . Due to its prominent role in normal vascular physiology, decreased NO bioavailability results in numerous detrimental effects to the endothelium. First, a lack of NO may induce ECs to enter early senescence, or permanent exit from the cell cycle. During each cell division, short sections of telomeres located at the ends of chromosomes are lost due to limitations of cellular replication machinery. If telomeres become too short, the cell responds by undergoing apoptosis or entering senescence in order to prevent further chromosome deterioration. Normally, the process of telomere shortening is precluded by the enzyme telomerase, which functions to extend the end of the telomeres during each replication cycle. Endothelial dysfunction may, in part, be due to a progressive decline in endothelial telomerase activity, resulting in premature cellular senescence. Once ECs become senescent, many structural and morphological changes occur, as well as changes in gene expression. Specifically, ECs exhibit increased expression of inflammatory adhesion molecules and decreased NO production (Minamino et al., 2002) . These changes may additionally enhance vascular aging and perpetuate endothelial dysfunction. In addition, NO can delay EC senescence by activating telomerase, thus protecting telomere deterioration and premature exit from the cell cycle (Vasa et al., 2000) . Therefore, decreased NO bioavailability results in decreased telomerase activity and an increased risk of entering senescence. Importantly, senescent ECs have been shown to have a similar phenotype as atherosclerotic ECs and localize to sites of atherosclerotic plaques (Minamino and Komuro, 2007) . These results provide further evidence of the role of EC senescence in cardiovascular disease.
Another consequence of reduced NO levels is increased oxidative stress within the endothelium. During times of oxidative stress, there is increased production harmful metabolic byproducts such as reactive oxygen species (ROS). ROS has numerous physiological roles within the cell and is known to be an important signaling molecule within ECs. However, excess ROS can lead to unregulated inflammatory signaling and contributes to the development of cardiovascular diseases such as atherosclerosis. Therefore, levels of ROS within the cell are normally tightly regulated by superoxide scavengers and antioxidants, such as NO (Forstermann, 2008; Kondo et al., 2009 ). Endothelial dysfunction is often accompanied by an imbalance of NO and ROS within the endothelium. Excess ROS can lead to oxidation of circulating low density lipoproteins (LDL) and increased expression of adhesion molecules such as intercellular adhesion molecule-1 (ICAM-1) or vascular adhesion molecule-1 (VCAM-1) (Kondo et al., 2009) . These changes promote some of the earliest known stages of atherosclerosis. Additionally, ROS decreases NO bioactivity through oxidative inactivation of the vasodilator, further impairing vessel function (Forstermann, 2008) . As blood vessels age, increased oxidative stress and ROS production masks the protective properties of NO, challenging the function and integrity of the vessel wall.
The overall reduction in NO bioavailability seen in aged blood vessels is largely due to a marked reduction in endothelial nitric oxide synthase (eNOS) activity. eNOS functions to catalyze the production of NO, which then diffuses from the endothelium to mediate its numerous physiologic effects. eNOS can be activated via numerous mechanisms. However, one of the most potent activators of eNOS is the parallel frictional force exerted on the endothelial layer by blood flow, called fluid shear stress (Malek et al., 1999) . Previous studies have shown that the reduction in NO availability in older vessels is partially due to impaired NO release in aging vessels in response to shear stress (Kang et al., 2009) . Aged ECs become less responsive to shear stress and do not produce sufficient levels of NO to maintain vascular homeostasis and experience impaired dilation. Importantly, decreased eNOS activity and NO deficiency is a hallmark on initiating factor of endothelial dysfunction and vascular aging. As a potent activator of eNOS and subsequent NO production, understanding how shear stress influence ECs in both health and disease has been under intense investigation.
Function of ECs and Influence of Shear Stress
ECs line the lumen of all blood vessels and form the interface between circulating blood and the underlying tissue. Therefore, proper function and maintenance of the endothelium in essential not only for cardiovascular health, but also for health of all tissues. The endothelium is not only responsible for providing sufficient oxygen and nutrients to underlying tissue, but also must dynamically respond to the changes in local hemodynamic environments, as circulating blood continually sweeps over the endothelial layer.
The endothelium is constantly subjected to fluid shear stress produced by blood flow, and numerous in vitro and in vivo studies have demonstrated how shear stress greatly influences EC phenotype. The magnitude of the force produced by blood flow, as well as the direction of flow can have marked effects on cellular behavior. In regions of the vasculature where blood flow is low (<5dyn/cm2) and disturbed, ECs are polygonal and in an activated state, promoting the development of atherosclerotic plaques. In contrast, ECs in regions of the vessel exposed to unidirectional, laminar flow are quiescent due to an atheroprotective gene expression profile (Davies, 1995) . Risk factors such as high cholesterol, lipoproteins, and coagulation factors are important for the onset of atherosclerosis and uniformly affect the entire systemic vasculature. However, interestingly, atherosclerosis is a highly focal disease, with plaques developing at distinct sites, such as vessel bifurcations or regions of curvature. Notably, these specific sites coincide with regions of the vasculature exposed to disturbed blood flow or low fluid shear stress. While there are many well-established risk factors associated with the development of cardiovascular disease, such as aging, sedentary lifestyle, or diet, local hemodynamic forces generated by fluid shear stress mediate the sitespecific development of atherosclerotic plaques. Therefore, the ability of ECs to sense blood flow and respond accordingly is not only critical for physiologic maintenance of vascular homeostasis and overall cardiovascular health, but is also critical for the development of cardiovascular diseases, such as atherosclerosis.
Endothelial cell responses to flow
As shear stress has emerged as a major regulator of EC function and phenotype in cardiovascular physiology and pathology, there has been an increasing drive to understand the role of fluid shear stress in EC biology. In this regard, it is known that ECs dynamically respond to shear stress by converting the mechanical force produced by blood flow into intracellular biochemical signals. Numerous in vitro studies have described EC responses to shear stress. These responses have been characterized temporally in the following categories. Some of the earliest EC responses to shear stress, occurring within seconds after the onset of flow, involve activation of specific channels or proteins associated with the plasma membrane. These changes include the opening of transmembrane K + and Ca 2+ channels (Naruse and Sokabe, 1993; Olesen et al., 1988; Yoshikawa et al., 1997) , activation of heterotrimeric G-proteins (Gudi et al., 1998) , and phosphorylation of the transmembrane adhesion molecule platelet endothelial cell adhesion molecule-1 (PECAM-1) (Osawa et al., 1997) . Additionally, within minutes, numerous intracellular signaling cascades are activated; including calcium-dependent phosphorylation and activation of eNOS, resulting in increase NO production (Gudi et al., 1998) , PI3-kinase activation, and signaling through integrins (Tzima et al., 2001 ).
On a slightly longer timescale, within minutes to hours, shear stress leads to activation of Rho family GTPases (Birukov et al., 2002; Li et al., 1999; Tzima, 2006; Tzima et al., 2002; Tzima et al., 2001; Tzima et al., 2003; Wojciak-Stothard and Ridley, 2003) , as well as activation and phosphorylation of other signaling molecules such as the adaptor protein Shc, c-Src, focal adhesion kinase (FAK) (Li et al., 1997) , MAP kinases (Tseng et al., 1995) , Protein kinase C (PKC) (Traub et al., 1997) , and jun C-terminal kinase (JNK) (Li et al., 1997) . Activation of these signaling molecules, as well as others, mediates numerous intracellular signaling cascades that are spatially and temporally coordinated to elicit an cumulative cellular response. Shear stress also initiates production of ROS in ECs within minutes (Hsieh et al., 1998) and mediates long term cellular effects through activation of various shear stress-responsive transcription factors, such as c-fos, c-jun, c-myc, and NF-κB (Khachigian et al., 1995) . Activation of these transcription factors affects expression of their respective targeted genes.
Following sustained exposure to shear stress on the time course of hours to days, the cell adapts by increasing expression of Kruppel-like factor 2 (KLF2) (Dekker et al., 2002; SenBanerjee et al., 2004 ), E-selectin, intercellular adhesion molecule-1 (ICAM-1), platelet derived growth factor (PDGF), tissue factor, transforming growth factor (TGF-B) and monocyte chemoattractant protein (MCP-1) (Khachigian et al., 1995; Nagel et al., 1994; Resnick et al., 1993; Sampath et al., 1995) . Additionally, ECs exhibit upregulation of eNOS, as well as downregulation of the vasoconstrictor endothelin-1 (ET-1) (Malek et al., 1993) . Therefore, it is known that sustained shear stress can affect overall vascular tone via regulation of various vasodilators and vasoconstrictors. Distinct structural and morphological changes also occur following sustained exposure to flow. Prolonged fluid shear stress results in reorientation of the actin cytoskeleton, microtubules, and intermediate filaments in the direction of flow (Girard and Nerem, 1995; Levesque and Nerem, 1985; Malek and Izumo, 1996) . These structural changes allow the cell to adapt to blood flow and reduce the mechanical load exerted on the endothelial layer (Davies, 1995; Girard and Nerem, 1993) . Changes in cellular architecture also result in EC elongation in the direction of blood flow. Integration of various signaling cascades and cellular adaptations in response to fluid shear stress continually mediate EC phenotype and overall vessel integrity.
EC sites of the signaling
In order to convert fluid shear stress into various signals, ECs transduce the mechanical force produced by blood flow into intracellular biochemical signals at numerous sites via mechanosensitive molecules called mechanotransducers. Numerous potential mechanotransducers have been proposed, including ion channels, G-protein coupled receptors (GPCRs), the cytoskeleton, and adhesion molecules.
Ion channels and GPCRs
Many apical surface proteins such as ion channels or GPCRs have been proposed to be shear stress sensors. Numerous studies have shown hyperpolarization of the EC membrane in response to shear stress due to activation of potassium channels (Hoger et al., 2002; Nakache and Gaub, 1988; Olesen et al., 1988) . This membrane hyperpolarization can be antagonized by membrane depolarization due to opening of transmembrane chloride channels (Barakat et al., 1999) Additionally, activation of calcium channels and intracellular calcium signaling in response to shear stress has also be shown to be important sheardependent activation of eNOS, subsequent vessel dilation, and overall vascular tone (Ando et al., 1993; Yamamoto et al., 2000) . Finally, membrane-associated GPCRs, have been shown to respond to shear stress. One such example is the bradykinin B 2 GPCR. Fluid shear stress elicits a conformational change in the B 2 GPCR independent of ligand binding (Chachisvilis et al., 2006) . Ligand-independent conformational changes in GPCRs has led to the hypothesis that these receptors may be important for mediating mechanotransduction signaling events in ECs.
Cytoskeleton
The cytoskeleton is a critical structural component of ECs and is hypothesized to be important for transducing forces and signaling events throughout the cell. The actin cytoskeleton, as well as intermediate filaments and microtubules, are important structural components that link disconnected regions throughout the cell. A model of tensegrity has been proposed to describe the structural properties of the cytoskeleton, where a series of interconnected compression-resistant structures are surrounded by tensional elements, creating an internal tension that provides cellular structure and support. Application of force to the entire structure results in rearrangement of cytoskeletal elements without loss of tension. Rearrangement of cytoskeleton elements may result in local activation of signaling molecules in response to shear stress (Ingber, 1993) . However, it remains unclear if the cytoskeleton acts directly as a mechanotransducer or rather functions as a scaffold to coordinate spatial regulation of intracellular signaling events.
Adhesion Proteins
It has been proposed that shear stress is transmitted from the apical surface exposed to blood flow through the cytoskeleton to points of attachment, allowing the cell to adapt to mechanical load and resist drag force. Therefore, adhesion molecules at located points of attachment are possible mechanotransducers, as they experience changes associated with shear stress. Integrins are transmembrane adhesion proteins whose extracellular domains binds directly to extracellular matrix proteins, while their cytoplasmic domains interact with the cytoskeleton, as well as important signaling molecules associated with focal adhesions (Burridge and Chrzanowska-Wodnicka, 1996) . Integrins are activated in response to shear stress and mediate downstream signaling events, including activation of RhoA and cytoskeletal alignment (Tzima et al., 2001 ). In addition, direct force application using magnetic beads has proven integrins to be capable of transducing force into intracellular signaling events (Wang et al., 1993) .
The adhesion molecule PECAM-1 has also been implicated as a shear stress sensor (Osawa et al., 1997) . Our work has implicated a mechanosensory complex located at endothelial cell-cell junctions composed of PECAM-1, VE-cadherin, and VEGFR2 capable of sensing fluid shear stress. In this complex, PECAM-1 acts as the mechanotransducer, leading to shear stress-dependent VEGFR2 activation, while VE-cadherin serves as an adaptor protein.
Signaling through the mechanosensory complex leads to subsequent activation of PI3-kinase, as well as integrin activation (Tzima et al., 2005) . Signaling through integrins also elicits subsequent changes in Rho family GTPase activity and cytoskeletal reorganization. In support of this hypothesis, ECs lacking PECAM-1 fail to activate many signaling molecules in response to shear stress and do not align in the direction of blood flow.
Potential Therapies
As new insights into EC biology emerge, advances in pharmacologic treatments and potential therapies are being pursued. Effective therapies must be able to overcome the deficiency in shear stress-induced NO production and bioavailability. In addition to a decline in physiological processes, aging is also associated with a decrease in physical activity, which negatively influences cardiovascular health and function. Recent studies have shown that increased insensitivity to fluid shear stress in aging vessels and ECs may be attenuated by increased physical exercise. Physical activity and exercise increase laminar fluid shear stress in the vasculature and elicit rapid upregulation of eNOS mRNA and protein expression levels (Haram et al., 2008) . Increased eNOS expression enhances NO bioavailability, benefiting the endothelium. Importantly, exercise-induced shear stress and NO production have been shown to be independent of both age and sex (Di Francescomarino et al., 2009) . Additional studies have also demonstrated that the use of Larginine, the precursor of nitric oxide, as nutritional therapy may potentially attenuate cardiovascular disease by increasing available NO levels (Heffernan et al., 2010 ). An ideal therapy may modify mechanosignaling cascades in ECs and, therefore, have the potential to interrupt the course of cardiovascular disease. However, as specific mechanisms of mechanotransduction remain elusive, more work needs to be done in order to identify the molecular interactions required for activation of the intracellular pathways responsible for inflammation and atherogenesis associated with vascular aging.
